Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00710203 · ClinicalTrials.gov registry record · NA

Dermatosis Papulosa Nigra

A NA study, sponsored by University of California, Davis.

Completed
Registry status
NA
Development phase
10
Enrollment target

NCT00710203: Completed NA study, sponsored by University of California, Davis.

NCT00710203 is a NA study that has completed, run by University of California, Davis. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00710203, a NA study, has completed, sponsored by University of California, Davis.

COMPLETED
Registry status
NA
Development phase
10 participants
Enrollment target

Study Summary

DPN is a disorder among darkly pigmented patients, manifested by small, benign, variants of seborrheic keratoses, predominantly on the face. The purpose of this study is to determine the efficacy of a 585 nm PDL for the treatment of Dermatosis Papulosa Nigra, and compare it to therapy with curettage (scraping the lesions off) and electrodesiccation (burning the lesions off).

Primary Outcome

The physician assessed percent clearance of all treated lesions and the control lesion.

Interventions

  • OTHER No treatment
  • DEVICE Pulsed dye laser
  • PROCEDURE Curettage
  • PROCEDURE Electrodesiccation

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2008-07
Est. Completion 2009-12
Phase NA
University of California, Davis

657 total trials

What the finished NCT00710203 record still lists

NCT00710203 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 4 interventions - of which No treatment is the first listed.

NCT00710203 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00710203 about?

NCT00710203 is a clinical study titled "Dermatosis Papulosa Nigra". DPN is a disorder among darkly pigmented patients, manifested by small, benign, variants of seborrheic keratoses, predominantly on the face. The purpose of this study is to determine the efficacy of a 585 nm PDL for the treatment of Dermatosis Papulosa Nigra, and compare it to therapy with curettag...

What is the current status of trial NCT00710203?

This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2008-07. Estimated completion is 2009-12.

What interventions are being tested in trial NCT00710203?

The interventions under investigation include: No treatment (OTHER), Pulsed dye laser (DEVICE), Curettage (PROCEDURE), Electrodesiccation (PROCEDURE).

Who is sponsoring clinical trial NCT00710203?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00710203's enrollment target sits among peer trials

10 1927th of 2000 higher than 26 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00710203, the US trial registry maintained by the National Library of Medicine. NCT00710203 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.